Development of high-performing stable producer cell lines for therapeutic AAV vector manufacturing

Authors

• Gang Li, Lonza Houston, USAFollow
• Natalie Knowles, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Chien-Ting Li, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Tam Doung, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Fernando Lugo, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Anitha Jayapalan, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Leila Aneke, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Phi Le, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• F. Michael Haller, Research & Development, Lonza Houston Inc., Houston, TX, 77578
• Bingnan Gu, Research & Development, Lonza Houston Inc., Houston, TX, 77578

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Gang Li, Natalie Knowles, Chien-Ting Li, Tam Doung, Fernando Lugo, Anitha Jayapalan, Leila Aneke, Phi Le, F. Michael Haller, and Bingnan Gu, "Development of high-performing stable producer cell lines for therapeutic AAV vector manufacturing" in "Advancing Manufacture of Cell and Gene Therapies IX [2026]", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/81